| AB | Arteannuin B |
| ACT | Artemisinin combination therapy |
| ART | Artemisinin |
| cGMP | Current Good Manufacturing Practice |
| dART | Deoxyartemisinin |
| DW | Dry weight |
| FDA | Food and Drug Administration |
| FL | Florida |
| GCMS | Gas chromatography–mass spectroscopy |
| IND | Investigational new drug |
| MA | Massachusetts |
| PCA | Principal component analysis |
| RH | Relative humidity |
| SAM | A clonal cultivar of A. annua L. |
| TLC | Thin layer chromatography |
| WHA | World Health Administration |
| WHO | World Health Organization |